KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAmortization of Deferred ChargesAmortization of GoodwillCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Evolent Health (EVH) Change in Receivables (2016 - 2018)

Evolent Health has reported Change in Receivables over the past 4 years, most recently at -$9.9 million for Q3 2018.

  • Quarterly results put Change in Receivables at -$9.9 million for Q3 2018, down 248.5% from a year ago — trailing twelve months through Sep 2018 was $17.4 million (up 20.05% YoY), and the annual figure for FY2017 was $11.3 million, up 1.94%.
  • Change in Receivables for Q3 2018 was -$9.9 million at Evolent Health, down from $4.2 million in the prior quarter.
  • Over the last five years, Change in Receivables for EVH hit a ceiling of $16.9 million in Q1 2018 and a floor of -$10.2 million in Q2 2015.
  • Median Change in Receivables over the past 4 years was $4.1 million (2017), compared with a mean of $1.6 million.
  • Peak annual rise in Change in Receivables hit 323.11% in 2018, while the deepest fall reached 248.5% in 2018.
  • Evolent Health's Change in Receivables stood at -$8.1 million in 2015, then skyrocketed by 216.63% to $9.4 million in 2016, then crashed by 34.5% to $6.2 million in 2017, then tumbled by 259.34% to -$9.9 million in 2018.
  • The last three reported values for Change in Receivables were -$9.9 million (Q3 2018), $4.2 million (Q2 2018), and $16.9 million (Q1 2018) per Business Quant data.